- Home
- Publications
- Publication Search
- Publication Details
Title
PPAR control of metabolism and cardiovascular functions
Authors
Keywords
-
Journal
Nature Reviews Cardiology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-15
DOI
10.1038/s41569-021-00569-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PPARs in liver physiology
- (2021) Alexandre Berthier et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Abrogation of postprandial triglyceridemia with dual PPAR α/γ agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study
- (2020) Ashu Rastogi et al. ACTA DIABETOLOGICA
- Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis
- (2020) Mohammad Zarei et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Reduction of cardiovascular risk in patients with T2DM by GLP-1 receptor agonists: a shift in paradigm driven by data from large cardiovascular outcome trials
- (2020) Nikolaus Marx EUROPEAN HEART JOURNAL
- Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages
- (2020) Sander Lefere et al. JOURNAL OF HEPATOLOGY
- Chronic activation of hexosamine biosynthesis in the heart triggers pathological cardiac remodeling
- (2020) Diem Hong Tran et al. Nature Communications
- Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content
- (2020) Yusuke Sasaki et al. Scientific Reports
- Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
- (2020) Marion Régnier et al. Scientific Reports
- Prolonged-release pirfenidone prevents obesity-induced cardiac steatosis and fibrosis in a mouse NASH model
- (2020) Jorge Gutiérrez-Cuevas et al. CARDIOVASCULAR DRUGS AND THERAPY
- Increasing Fatty Acid Oxidation Prevents High Fat Diet Induced Cardiomyopathy through Regulating Parkin Mediated Mitophagy
- (2020) Dan Shao et al. CIRCULATION
- SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
- (2020) Martin R. Cowie et al. Nature Reviews Cardiology
- Obesity-Linked PPARγ S273 Phosphorylation Promotes Insulin Resistance through Growth Differentiation Factor 3
- (2020) Jessica A. Hall et al. Cell Metabolism
- MED19 Regulates Adipogenesis and Maintenance of White Adipose Tissue Mass by Mediating PPARγ-Dependent Gene Expression
- (2020) John M. Dean et al. Cell Reports
- Dysregulated lipid metabolism links NAFLD to cardiovascular disease
- (2020) Audrey Deprince et al. Molecular Metabolism
- The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure
- (2020) Ahmad A. Cluntun et al. Cell Metabolism
- Hepatic PPARα is critical in the metabolic adaptation to sepsis
- (2019) Réjane Paumelle et al. JOURNAL OF HEPATOLOGY
- PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis
- (2019) Caiyun G. Li et al. Cell Reports
- AMPK and PPARβ positive feedback loop regulates endurance exercise-mediated GLUT4 expression in skeletal muscle
- (2019) Jin-Ho Koh et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
- (2019) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα
- (2019) Ning Liang et al. Nature Communications
- The class 3 PI3K coordinates autophagy and mitochondrial lipid catabolism by controlling nuclear receptor PPARα
- (2019) Anton Iershov et al. Nature Communications
- The loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity
- (2019) David E. Stec et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool
- (2019) Stefan Jordan et al. CELL
- Fenofibrate increases very-long-chain sphingolipids and improves blood glucose homeostasis in NOD mice
- (2019) Laurits J. Holm et al. DIABETOLOGIA
- Atherosclerosis
- (2019) Peter Libby et al. Nature Reviews Disease Primers
- TAZ Is a Negative Regulator of PPARγ Activity in Adipocytes and TAZ Deletion Improves Insulin Sensitivity and Glucose Tolerance
- (2019) Dalila El Ouarrat et al. Cell Metabolism
- Metabolic Remodeling Promotes Cardiac Hypertrophy by Directing Glucose to Aspartate Biosynthesis
- (2019) Julia Ritterhoff et al. CIRCULATION RESEARCH
- Complementary Immunometabolic Effects of Exercise and PPARβ/δ Agonist in the Context of Diet-Induced Weight Loss in Obese Female Mice
- (2019) Sébastien Le Garf et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Brown Adipocyte-Specific PPARγ (Peroxisome Proliferator-Activated Receptor γ) Deletion Impairs Perivascular Adipose Tissue Development and Enhances Atherosclerosis in Mice
- (2018) Wenhao Xiong et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Diabetic Cardiomyopathy
- (2018) Guanghong Jia et al. CIRCULATION RESEARCH
- Coordination Among Lipid Droplets, Peroxisomes and Mitochondria Regulates Energy Expenditure Through the CIDE-ATGL-PPARα Pathway in Adipocytes
- (2018) Linkang Zhou et al. DIABETES
- Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
- (2018) Eiichi Araki et al. DIABETES CARE
- Molecular actions of PPARα in lipid metabolism and inflammation
- (2018) Nadia Bougarne et al. ENDOCRINE REVIEWS
- PPARγ is a nexus controlling alternative activation of macrophages via glutamine metabolism
- (2018) Victoria L. Nelson et al. GENES & DEVELOPMENT
- Hepatic PPARα function is controlled by polyubiquitination and proteasome-mediated degradation through the coordinated actions of PAQR3 and HUWE1
- (2018) Zilong Zhao et al. HEPATOLOGY
- Endothelial PPARγ (Peroxisome Proliferator–Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With AgingNovelty and Significance
- (2018) T. Michael De Silva et al. HYPERTENSION
- A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice
- (2018) Masami Sairyo et al. Journal of Atherosclerosis and Thrombosis
- Krüppel-like factor 10 (KLF10) is transactivated by the transcription factor C/EBPβ and involved in early 3T3-L1 preadipocyte differentiation
- (2018) Yuan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PPARγ deacetylation dissociates thiazolidinedione’s metabolic benefits from its adverse effects
- (2018) Michael J. Kraakman et al. JOURNAL OF CLINICAL INVESTIGATION
- Fasting-induced JMJD3 histone demethylase epigenetically activates mitochondrial fatty acid β-oxidation
- (2018) Sunmi Seok et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial
- (2018) Shun Ishibashi et al. Journal of Clinical Lipidology
- Metabolic remodelling in heart failure
- (2018) Edoardo Bertero et al. Nature Reviews Cardiology
- An Hsp20-FBXO4 Axis Regulates Adipocyte Function through Modulating PPARγ Ubiquitination
- (2018) Jiangtong Peng et al. Cell Reports
- Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
- (2018) Mohammad Zarei et al. Molecular Metabolism
- Emerging Roles for Adipose Tissue in Cardiovascular Disease
- (2018) Elizabeth E. Ha et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Diet-Induced Circadian Enhancer Remodeling Synchronizes Opposing Hepatic Lipid Metabolic Processes
- (2018) Dongyin Guan et al. CELL
- Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice
- (2018) Chad N. Brocker et al. JOURNAL OF LIPID RESEARCH
- TET2 facilitates PPARγ agonist–mediated gene regulation and insulin sensitization in adipocytes
- (2018) Fuyun Bian et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Complementary intestinal mucosa and microbiota responses to caloric restriction
- (2018) Kalina Duszka et al. Scientific Reports
- Peroxisome Proliferator-Activated Receptor γ2 Controls the Rate of Adipose Tissue Lipid Storage and Determines Metabolic Flexibility
- (2018) Sam Virtue et al. Cell Reports
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
- (2018) Aruna D. Pradhan et al. AMERICAN HEART JOURNAL
- Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
- (2018) Arun Sanyal et al. LANCET
- The role of adipose tissue in cardiovascular health and disease
- (2018) Evangelos K. Oikonomou et al. Nature Reviews Cardiology
- PPARγ-K107 SUMOylation regulates insulin sensitivity but not adiposity in mice
- (2018) Takeshi Katafuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct but complementary contributions of PPAR isotypes to energy homeostasis
- (2017) Vanessa Dubois et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor knockout mice
- (2017) Kenta Takei et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
- (2017) Mariana X. Byndloss et al. SCIENCE
- Endothelial LRP1 regulates metabolic responses by acting as a co-activator of PPARγ
- (2017) Hua Mao et al. Nature Communications
- Commensal gut bacteria modulate phosphorylation-dependent PPARγ transcriptional activity in human intestinal epithelial cells
- (2017) Malgorzata Nepelska et al. Scientific Reports
- Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
- (2017) Marcela Doktorova et al. Scientific Reports
- Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer
- (2016) K. J. Mather et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
- (2016) Nathalie Hennuyer et al. ATHEROSCLEROSIS
- Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction
- (2016) Marta Toral et al. BIOCHEMICAL PHARMACOLOGY
- Triacylglycerol turnover in the failing heart
- (2016) Andrew N. Carley et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Hypoxia-driven glycolytic and fructolytic metabolic programs: Pivotal to hypertrophic heart disease
- (2016) Peter Mirtschink et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The Failing Heart Relies on Ketone Bodies as a Fuel
- (2016) Gregory Aubert et al. CIRCULATION
- Lipid Use and Misuse by the Heart
- (2016) P. Christian Schulze et al. CIRCULATION RESEARCH
- Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
- (2016) Ele Ferrannini et al. DIABETES
- On the pivotal role of PPARα in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury
- (2016) Mark A. Cole et al. FASEB JOURNAL
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
- (2016) Alexandra Montagner et al. GUT
- Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice
- (2016) Abigail Wolf Greenstein et al. JOURNAL OF ENDOCRINOLOGY
- Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
- (2016) Sven M. Francque et al. JOURNAL OF HEPATOLOGY
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
- (2016) Barbara Gross et al. Nature Reviews Endocrinology
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine
- (2016) Julie Tomas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNMT1-PPARγ pathway in macrophages regulates chronic inflammation and atherosclerosis development in mice
- (2016) Jie Yu et al. Scientific Reports
- Activation of PPAR-δ induces microRNA-100 and decreases the uptake of very low-density lipoprotein in endothelial cells
- (2015) Xi Fang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Fenofibrate Reverses Palmitate Induced Impairment in Glucose Uptake in Skeletal Muscle Cells by Preventing Cytosolic Ceramide Accumulation
- (2015) Sudarshan Bhattacharjee et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Cardiac Myocyte KLF5 Regulates Ppara Expression and Cardiac FunctionNovelty and Significance
- (2015) Konstantinos Drosatos et al. CIRCULATION RESEARCH
- Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation
- (2015) Gijs den Besten et al. DIABETES
- Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction
- (2015) Sairia Dass et al. EUROPEAN HEART JOURNAL
- Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus
- (2015) Eylem Levelt et al. EUROPEAN HEART JOURNAL
- Mitochondrial biogenesis and dynamics in the developing and diseased heart
- (2015) Gerald W. Dorn et al. GENES & DEVELOPMENT
- Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model
- (2015) XIULI LI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy?
- (2015) Alaa Othman et al. Journal of Clinical Lipidology
- PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
- (2015) Sven Francque et al. JOURNAL OF HEPATOLOGY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice
- (2015) Tamiris Lima Rachid et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- PPARs: Protectors or Opponents of Myocardial Function?
- (2015) Christine J. Pol et al. PPAR Research
- KLF15 and PPARαCooperate to Regulate Cardiomyocyte Lipid Gene Expression and Oxidation
- (2015) Domenick A. Prosdocimo et al. PPAR Research
- Sequestration of fatty acids in triglycerides prevents endoplasmic reticulum stress in an in vitro model of cardiomyocyte lipotoxicity
- (2014) Madeleen Bosma et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes
- (2014) Raymond E. Soccio et al. Cell Metabolism
- Dietary Fat Supply to Failing Hearts Determines Dynamic Lipid Signaling for Nuclear Receptor Activation and Oxidation of Stored Triglyceride
- (2014) Ryan Lahey et al. CIRCULATION
- Myocardial Contractile Dysfunction Is Associated With Impaired Mitochondrial Function and Dynamics in Type 2 Diabetic but Not in Obese Patients
- (2014) David Montaigne et al. CIRCULATION
- microRNA-34a and microRNA-34c promote the activation of human hepatic stellate cells by targeting peroxisome proliferator-activated receptor γ
- (2014) XIAOFEI LI et al. Molecular Medicine Reports
- The Hypoxia-Inducible MicroRNA Cluster miR-199a∼214 Targets Myocardial PPARδ and Impairs Mitochondrial Fatty Acid Oxidation
- (2013) Hamid el Azzouzi et al. Cell Metabolism
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- Peroxisome Proliferator–Activated Receptor-γ Activation Prevents Sepsis-Related Cardiac Dysfunction and Mortality In Mice
- (2013) Konstantinos Drosatos et al. Circulation-Heart Failure
- PPARγ-induced PARylation promotes local DNA demethylation by production of 5-hydroxymethylcytosine
- (2013) Katsunori Fujiki et al. Nature Communications
- Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ
- (2012) Li Qiang et al. CELL
- PPAR Activation Protects Endothelial Function in Diabetic Mice
- (2012) X. Y. Tian et al. DIABETES
- Activation of intestinal peroxisome proliferator-activated receptor- increases high-density lipoprotein production
- (2012) S. Colin et al. EUROPEAN HEART JOURNAL
- Effects of PPARs Agonists on Cardiac Metabolism in Littermate and Cardiomyocyte-Specific PPAR-γ –Knockout (CM-PGKO) Mice
- (2012) Michelangela Barbieri et al. PLoS One
- Krüppel-Like Factor KLF8 Plays a Critical Role in Adipocyte Differentiation
- (2012) Haemi Lee et al. PLoS One
- In VitroandIn VivoCharacterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist
- (2012) B. K. He et al. PPAR Research
- Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice
- (2011) Alex Morrison et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia
- (2011) Yun-Jung Choi et al. ATHEROSCLEROSIS
- Cardiac Raptor Ablation Impairs Adaptive Hypertrophy, Alters Metabolic Gene Expression, and Causes Heart Failure in Mice
- (2011) Pankaj Shende et al. CIRCULATION
- The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation
- (2011) Emma Barroso et al. ENDOCRINOLOGY
- PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production
- (2011) Mehdi Daoudi et al. GASTROENTEROLOGY
- Peroxisome Proliferator-Activated Receptor β/δ Activation in Adult Hearts Facilitates Mitochondrial Function and Cardiac Performance Under Pressure-Overload Condition
- (2011) Jian Liu et al. HYPERTENSION
- Peroxisome Proliferator-activated Receptor (PPAR) Gene Profiling Uncovers Insulin-like Growth Factor-1 as a PPARα Target Gene in Cardioprotection
- (2011) Hamid el Azzouzi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peroxisome Proliferator-activated Receptor α (PPARα) Induces PPARγ Coactivator 1α (PGC-1α) Gene Expression and Contributes to Thermogenic Activation of Brown Fat
- (2011) Elayne Hondares et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
- (2011) Harold E. Bays et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance
- (2011) Janet B. McGill et al. JOURNAL OF NUCLEAR CARDIOLOGY
- ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
- (2011) Guenter Haemmerle et al. NATURE MEDICINE
- Preferential Oxidation of Triacylglyceride-Derived Fatty Acids in Heart Is Augmented by the Nuclear Receptor PPARα
- (2010) Natasha H. Banke et al. CIRCULATION RESEARCH
- Analysis of Metabolic Remodeling in Compensated Left Ventricular Hypertrophy and Heart Failure
- (2010) Takao Kato et al. Circulation-Heart Failure
- PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation
- (2010) Ni-Huiping Son et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Myocardial Fatty Acid Metabolism in Health and Disease
- (2010) Gary D. Lopaschuk et al. PHYSIOLOGICAL REVIEWS
- ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-β/δ ATTENUATES MYOCARDIAL ISCHEMIA/REPERFUSION INJURY IN THE RAT
- (2010) Amar Kapoor et al. SHOCK
- Activation of a HIF1α-PPARγ Axis Underlies the Integration of Glycolytic and Lipid Anabolic Pathways in Pathologic Cardiac Hypertrophy
- (2009) Jaya Krishnan et al. Cell Metabolism
- Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome
- (2009) Raffaele Marfella et al. JOURNAL OF LIPID RESEARCH
- Adipocyte-Derived Th2 Cytokines and Myeloid PPARδ Regulate Macrophage Polarization and Insulin Sensitivity
- (2008) Kihwa Kang et al. Cell Metabolism
- The PPAR trio: Regulators of myocardial energy metabolism in health and disease
- (2008) Jose A. Madrazo et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-δ
- (2008) Yumiko Oishi et al. NATURE MEDICINE
- PPAR regulates multiple proinflammatory pathways to suppress atherosclerosis
- (2008) G. D. Barish et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibrates and future PPARα agonists in the treatment of cardiovascular disease
- (2008) Bart Staels et al. Nature clinical practice. Cardiovascular medicine
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started